Sponsors

Antimicrobial resistance detection expertise from Mast Group

Mast Group is a UK-based independent European manufacturer and supplier of clinical diagnostic products. Established in Liverpool in 1957, Mast Group has grown into a multinational company exporting globally.

The corporate headquarters are based in Bootle and Mast has subsidiary companies in Reinfeld (Mast Diagnostica) and Amiens, France (Mast Diagnostic).

Mast Group were among the first companies to commercialise the antibiotic disc, and continues to work with major pharmaceutical companies worldwide in the development of new products.

Mast Group focuses on the susceptibility, identification and resistance along with offering molecular and immunochemistry solutions for the IVD market. This is achieved through the
investment in personnel, R&D and infrastructure, including state-of-the-art manufacturing facilities on Merseyside. 

This enables Mast Group to provide tools to aid in the diagnosis of clinical disease, from pioneering antibiotic susceptibility testing to novel molecular solutions, Mast Group continues to
develop products for the ever-changing IVD market, creating solutions to support clinical diagnosis today and into the future.

www.mast-group.com

Latest Issues

Pathology Visions 24

Hyatt Regency, Orlando, FL
3-5 November, 2025

UK NEQAS Cellular Pathology Technique - Annual Participant’s Meeting

America Square Conference Centre, London, EC3N 2LB.
4 - 5 November, 2024

Medica

Messe Dusseldorf
11-14 November, 2024

POCT-for-Scot: Bringing the future to you

SEC Arena, Glasgow
14 November, 2024

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024